Treatment-Related Adverse Events of Antibody Drug Conjugates Identified

MONDAY, Nov. 21, 2022 (HealthDay News) -- Adverse effects associated with antibody-drug conjugates (ADCs) have been described in a review and meta-analysis published online Nov. 21 in Cancer.
Youwen Zhu, from Central South University in Changsha, China, and colleagues conducted a systematic review and meta-analysis of data obtained between Jan. 1, 2000, and June 7, 2022, to examine mechanisms of toxicity for ADCs. The primary outcome was the incidence of all-grade and grade ≥3 treatment-related adverse events. A total of 2,511 records were identified that included 169 clinical trials and 22,492 patients.
The researchers found that the overall incidence of treatment-related adverse events was 91.2 and 46.1 percent for all-grade adverse events and grade ≥3 adverse events, respectively. Lymphopenia, nausea, neutropenia, blurred vision, and peripheral neuropathy were the most common all-grade adverse events (53.0, 44.1, 43.7, 40.5, and 39.6 percent, respectively), while the most common grade ≥3 adverse events were neutropenia, hypoesthesia, thrombocytopenia, febrile neutropenia, and lymphopenia (31.2, 23.3, 22.6, 21.2, and 21.0 percent, respectively).
"Different ADCs appear to vary in their treatment-related adverse events," one coauthor said in a statement. "Our results provide an important reference for clinicians and patients on how to address ADCs' toxicity in clinical practice."
Related Posts
Awareness of the Link Between Alcohol, Cancer Is Low
THURSDAY, Dec. 1, 2022 (HealthDay News) -- Awareness of the link between alcohol...
Countries With Universal Health Care Had Better Child Vaccination Rates During Pandemic
THURSDAY, Aug. 18, 2022 (HealthDay News) -- Countries that are closer to...
Extreme Heat Exposure Tied to Faster Cognitive Decline in Vulnerable Populations
FRIDAY, Aug. 25, 2023 (HealthDay News) -- Extreme heat exposure can...
New Inflammatory Arthritis Diagnoses Down Early in Pandemic
WEDNESDAY, Nov. 9, 2022 (HealthDay News) -- During the early phase of the...
